IMP3 expression determines aggressive superficial urothelial carcinoma

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2008年 / 5卷 / 7期
关键词：
D O I：
10.1038/ncponc1142
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：364 / 364
相关论文
共 50 条
  • [1] IMP3 predicts aggressive superficial urothelial carcinoma of the bladder
    Sitnikova, Lioudmila
    Mendese, Gary
    Liu, Qin
    Woda, Bruce A.
    Lu, Di
    Dresser, Karen
    Mohanty, Sambit
    Rock, Kenneth L.
    Jiang, Zhong
    CLINICAL CANCER RESEARCH, 2008, 14 (06) : 1701 - 1706
  • [2] IMP3, a Prognostic Biomarker for Disease Progression in Superficial Urothelial Carcinoma
    Cornejo, K. M.
    Jiang, Z.
    Owens, C.
    LABORATORY INVESTIGATION, 2013, 93 : 204A - 204A
  • [3] IMP3, a Prognostic Biomarker for Disease Progression in Superficial Urothelial Carcinoma
    Cornejo, K. M.
    Jiang, Z.
    Owens, C.
    MODERN PATHOLOGY, 2013, 26 : 204A - 204A
  • [4] The RNA binding protein IMP3: A noval molecular marker to predict aggressive superficial urothelial carcinoma of the bladder
    Sitnikova, L.
    Liu, Q.
    Mendese, G.
    Woda, B. A.
    Lu, D.
    Rock, K. L.
    Jiang, Z.
    MODERN PATHOLOGY, 2007, 20 : 177A - 177A
  • [5] The RNA binding protein IMP3: A noval molecular marker to predict aggressive superficial urothelial carcinoma of the bladder
    Sitnikova, L.
    Liu, Q.
    Mendese, G.
    Woda, B. A.
    Lu, D.
    Rock, K. L.
    Jiang, Z.
    LABORATORY INVESTIGATION, 2007, 87 : 177A - 177A
  • [6] Imp3 Expression in Urothelial Carcinomas of the Urinary Bladder
    Ozdemir, Nihal Ozkalay
    Turk, Nilay Sen
    Duzcan, Ender
    TURKISH JOURNAL OF PATHOLOGY, 2011, 27 (01) : 31 - 37
  • [7] Oncofetal Proteins IMP3, Glypican-3 and TPBG Expression in Urothelial Carcinoma of the Bladder
    Khani, F.
    Xylinas, E.
    Cha, E.
    Volkmer, B.
    Kluth, L.
    Scherr, D. S.
    Rubin, M. A.
    Mosquera, J. M.
    Hautmann, R. E.
    Kuefer, R.
    Shariat, S. F.
    Robinson, B. D.
    LABORATORY INVESTIGATION, 2013, 93 : 225A - 226A
  • [8] Oncofetal Proteins IMP3, Glypican-3 and TPBG Expression in Urothelial Carcinoma of the Bladder
    Khani, F.
    Xylinas, E.
    Cha, E.
    Volkmer, B.
    Kluth, L.
    Scherr, D. S.
    Rubin, M. A.
    Mosquera, J. M.
    Hautmann, R. E.
    Kuefer, R.
    Shariat, S. F.
    Robinson, B. D.
    MODERN PATHOLOGY, 2013, 26 : 225A - 226A
  • [9] IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype
    Yang, Feiya
    Zhou, Qiang
    Meng, Lingquan
    Xing, Nianzeng
    MEDICINE, 2019, 98 (27)
  • [10] Immunohistochemical Expression of IMP3 in Cutaneous Basal Cell Carcinoma
    Bartos, Vladimir
    GALICIAN MEDICAL JOURNAL, 2022, 29 (03)
12345